Tag: Pricing
Business & Industry
AstraZeneca UK Investment Resumes with £300m Commitment
In a reversal of its earlier stance, AstraZeneca has confirmed a £300m commitment to the UK, marking a renewed push into domestic operations after...
Business & Industry
Trump Announces 100% US Pharma Tariffs for Patented Drugs
The US pharma tariffs policy has been formalised through an executive order signed by Donald Trump, introducing tariffs of up to 100% on imported...
Business & Industry
CMS Extends GENEROUS MFN Drug Pricing Deadline to April
The Centers for Medicare & Medicaid Services (CMS) in the US has moved to extend the enrolment window for its GENEROUS pilot programme, an...
Business & Industry
CMS Unveils a New Voluntary Access Programme For GLP-1
In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new...
Business & Industry
Novartis to Lower Innovative Medicines Price in the US
Novartis, which is a leading global innovative medicines company, went ahead and announced on December 19, 2025, that it has reached an agreement along with...
Business & Industry
New Agreements with Pharmaceuticals Target Lower U.S. Drug Prices
President Donald Trump on December 19, 2025, said that his administration has reached agreements with nine additional pharmaceutical companies, therefore extending a campaign that...
Business & Industry
Trump To Exempt UK-Origin Pharmaceuticals from Tariffs
The Trump administration has lined up yet another country-specific trade agreement, and this time it is going to be with the U.K., which confers...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read